0001104659-17-028860.txt : 20170502 0001104659-17-028860.hdr.sgml : 20170502 20170502155439 ACCESSION NUMBER: 0001104659-17-028860 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170501 FILED AS OF DATE: 20170502 DATE AS OF CHANGE: 20170502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DEPTULA-HICKS DARLENE M CENTRAL INDEX KEY: 0001089409 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 17804863 MAIL ADDRESS: STREET 1: C/O ICAD, INC. STREET 2: 98 SPIT BROOK ROAD, SUITE 100 CITY: NASHUA STATE: NH ZIP: 03062 4 1 a4.xml 4 X0306 4 2017-05-01 0 0001492674 T2 Biosystems, Inc. TTOO 0001089409 DEPTULA-HICKS DARLENE M 101 HARTWELL AVENUE LEXINGTON MA 02421 0 1 0 0 Chief Financial Officer Stock Option (Right to Buy) 4.74 2016-05-01 4 A 0 175000 0 A 2027-05-01 Common Stock 175000 175000 D 25% of the total shares vest on 05/01/2018, and the remaining shares vest in substantially equal monthly installments over the following 36 months, to be fully vested on 05/01/2021. /s/ Michael Gibbs, Attorney-in-fact 2017-05-01